Skip to main content
. 2023 Nov 23;10:1294808. doi: 10.3389/fmed.2023.1294808

TABLE 3.

Comparison of intraoperative parameters between groups.

Total (n = 78) Grade 2 nucleus (n = 27) Grade 3 nucleus (n = 51)
Active (n = 40) Gravity (n = 38) P-value Active (n = 15) Gravity (n = 12) P-value Active (n = 25) Gravity (n = 26) P-value
Total case time (seconds) 323.5 ± 151.7 372.3 ± 169.8 0.512 309.8 ± 153.1 345.5 ± 177.1 0.722 331.7 ± 156.2 384.7 ± 172.6 0.757
CDE (%-seconds) 5.52 ± 4.91 6.77 ± 5.52 0.613 1.93 ± 2.12 2.32 ± 2.57 0.587 7.67 ± 6.27 8.82 ± 7.91 0.498
EFU (ml) 38.0 ± 19.8 41.2 ± 28.5 0.719 29.9 ± 9.2 33.1 ± 12.8 0.439 42.9 ± 24.2 44.9 ± 35.7 0.951
OVDs usage (ml) 0.69 ± 0.54 0.72 ± 0.62 0.343 0.62 ± 0.33 0.66 ± 0.43 0.719 0.73 ± 0.71 0.75 ± 0.77 0.677
Patient pain level
No pain 33(82.5%) 11(28.9%) <0.0001 14(93.3%) 3(25.0%) 0.0001 19(76.0%) 8(30.8%) 0.005
Mild pain 6(15.0%) 19(50.0%) 1(6.7%) 6(50.0%) 5(20.0%) 13(50.0%)
Moderate pain 1(2.5%) 8(21.1%) 0(0%) 3(25.0%) 1(4.0%) 5(19.2%)
Severe pain 0(0%) 0(0%) 0(0%) 0(0%) 0(0%) 0(0%)

CDE, cumulative dissipated energy; EFU, estimated fluid usage; OVDs, ophthalmic viscoelastic devices.